Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,665,770 | 8,806,690 | 7,519,710 | 8,756,810 | 2,865,290 |
| Depreciation Amortization | 3,339,050 | 2,214,190 | 1,719,830 | 2,690,570 | 3,202,380 |
| Other Working Capital | 0 | 71,980 | -3,850,200 | -2,841,390 | 4,294,070 |
| Other Operating Activity | 525,740 | 208,120 | 1,545,470 | 1,421,510 | 148,460 |
| Operating Cash Flow | $8,530,560 | $11,300,980 | $6,934,810 | $10,027,500 | $10,510,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,957,940 | -1,787,000 | -1,558,150 | -1,320,420 | -1,523,100 |
| Net Acquisitions | 337,860 | 3,196,880 | 0 | 1,235,380 | -547,390 |
| Other Investing Activity | -156,570 | -589,930 | -2,612,240 | -94,650 | -817,990 |
| Investing Cash Flow | $-1,776,650 | $819,950 | $-4,170,390 | $-179,690 | $-2,888,480 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -6,333,640 | -5,758,460 | -6,045,570 | -5,464,580 | -4,955,890 |
| Other Financing Activity | -2,541,370 | -4,057,530 | 733,900 | -4,534,040 | -3,658,540 |
| Financing Cash Flow | $-8,875,010 | $-9,815,990 | $-5,311,670 | $-9,998,620 | $-8,614,430 |
| Exchange Rate Effect | 138,440 | -231,590 | -145,820 | -173,270 | 125,250 |
| Beginning Cash Position | 8,621,210 | 6,112,100 | 8,884,480 | 9,316,750 | 9,846,830 |
| End Cash Position | 6,638,540 | 8,185,460 | 6,191,400 | 8,992,660 | 8,979,360 |
| Net Cash Flow | $-1,982,660 | $2,073,360 | $-2,693,080 | $-324,080 | $-867,470 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,530,560 | 11,300,980 | 6,934,810 | 10,027,500 | 10,510,200 |
| Free Cash Flow | 8,530,560 | 11,300,980 | 6,934,810 | 10,027,500 | 10,510,200 |